It is reported that IL-32γ and IL-32β induce caspase-8-dependent cell death in HEK293 cells whereas IL-32α does not, and that the treatment of alternative splicing inhibitor results in the predominant expression of IL-32γ splice variants and cell death in thyroid cancer cell lines [42]. The gene discussed is CASP8; the disease is thyroid cancer.